Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients.
Valverde-Monge M, Sánchez-Carrasco P, Betancor D, Barroso B, Rodrigo-Muñoz JM, Mahillo-Fernández I, Arismendi E, Bobolea I, Cárdaba B, Cruz MJ, Del Pozo V, Domínguez-Ortega J, González-Barcala FJ, Olaguibel JM, Luna-Porta JA, Martínez-Rivera C, Mullol J, Muñoz X, Peleteiro-Pedraza L, Picado Valles C, Plaza V, Quirce S, Rial MJ, Soto-Retes L, Valero A, Sastre J. Valverde-Monge M, et al. Among authors: olaguibel jm. Arch Bronconeumol. 2024 Jan;60(1):23-32. doi: 10.1016/j.arbres.2023.11.011. Epub 2023 Nov 22. Arch Bronconeumol. 2024. PMID: 38042707 English, Spanish.
Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen.
Alvarez MJ, Echechipía S, García B, Tabar AI, Martín S, Rico P, Olaguibel JM. Alvarez MJ, et al. Among authors: olaguibel jm. Clin Exp Allergy. 2002 Nov;32(11):1574-82. doi: 10.1046/j.1365-2222.2002.01514.x. Clin Exp Allergy. 2002. PMID: 12569977 Clinical Trial.
Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire.
Justicia JL, Cardona V, Guardia P, Ojeda P, Olaguíbel JM, Vega JM, Vidal C, Baró E, García MA. Justicia JL, et al. Among authors: olaguibel jm. J Allergy Clin Immunol. 2013 Jun;131(6):1539-46. doi: 10.1016/j.jaci.2012.11.049. Epub 2013 Jan 23. J Allergy Clin Immunol. 2013. PMID: 23352631
[From rhinitis to asthma, one or two diseases?].
Alvarez MJ, Olaguíbel JM, Lasa E, Arroabarren E, Gómez A, Gómez B. Alvarez MJ, et al. Among authors: olaguibel jm. An Sist Sanit Navar. 2003;26 Suppl 2:49-55. An Sist Sanit Navar. 2003. PMID: 13679963 Free article. Review. Spanish.
Immunotherapy with a standardized Dermatophagoides pteronyssinus glutaraldehyde-modified extract against an unmodified extract: a comparative study of efficacy, tolerance and in vivo and in vitro modification of parameters.
Echechipía S, Tabar AI, Lobera T, Muñoz D, Rodríguez A, Blasco A, Olaguíbel JM, Casanovas M, Fernández de Corres L. Echechipía S, et al. Among authors: olaguibel jm. J Investig Allergol Clin Immunol. 1995 Nov-Dec;5(6):325-32. J Investig Allergol Clin Immunol. 1995. PMID: 8653220 Clinical Trial.
[Associations of allergic and asthmatic patients in Europe].
Parra A, Ferreiro H, Olaguíbel JM, García BE, Mina C, Azanza C, del Amo C. Parra A, et al. Among authors: olaguibel jm. An Sist Sanit Navar. 2003;26 Suppl 2:147-53. An Sist Sanit Navar. 2003. PMID: 13679974 Free article. Spanish.
110 results